Advertisement
Longeveron Inc.

Longeveron Inc. (LGVN) Stock Overview

Explore Longeveron Inc.’s financial performance, market position, analyst ratings, and future outlook.

LGVNNASDAQ
HealthcareBiotechnology
$0.77
$0.003(0.32%)
U.S. Market opens in 16h 43m
Advertisement

Longeveron Inc. (LGVN)

Meyka AI Score

Z

Key Financials

Market Cap15.4M
P/E Ratio-0.85
EPS (TTM)$-1.14
ROE-2.02%
Fundamental Analysis

AI Price Forecasts

1 Month$0.36
3 Months$0.00
1 Year Target$0.00

LGVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Longeveron Inc. (LGVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.85 and a market capitalization of 15.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.32%
5-Day Change
-3.73%
1-Month Change
-8.87%
3-Month Change
-13.56%
6-Month Change
22.80%
Year-to-Date (YTD) Change
52.21%
1-Year Change
-44.19%
3-Year Change
-97.90%
5-Year Change
-98.84%
All-Time (Max) Change
-98.96%

Contact Information

305 909 0840
1951 NW 7th Avenue, Miami, FL, 33136

Company Facts

25 Employees
IPO DateFeb 12, 2021
CountryUS
Actively Trading

Frequently Asked Questions